During cutting cycles, doses can be pushed higher since reducing appetite aligns with the goal of caloric restriction
Decades of outcome data later, we know that medication alone produces inferior results: patients who do best are the ones whose sleep, movement, nutrition, and connection are also addressed
Reductions in systolic and diastolic blood pressure, triglycerides, and markers of insulin resistance have also been observed, positioning retatrutide as a subject of broad interest across cardiometabolic research
If you are experiencing intolerable side effects, consult with your healthcare provider
The additional glucagon receptor activation is designed to increase energy expenditure, though head-to-head trials have not yet been conducted
Semaglutide focuses on GLP-1 and has been on the market longer, with proven results